Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Bone Marrow Transplantation

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2014.246PMID 25387094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparable survival for pediatric acute myeloid leukemia with poor‐risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation

  2014cited by this paper
• A critical review of which children with acute myeloid leukaemia need stem cell procedures

  2014cited by this paper
• Unrelated Cord Blood Transplantation For Infant Acute Leukemia Diagnosed Within 1 Year Of Age: Outcomes and Risk Factor Analysis On Behalf Of Eurocord and PDWP-EBMT

  2013cited by this paper
• Allo-SCT using BU, CY and melphalan for children with AML in second CR

  2013cited by this paper
• CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype.

  2013cited by this paper
• BCSH/BSBMT guideline: diagnosis and management of veno‐occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation

  2013cited by this paper
• Circulating plasma cells with Russell bodies in osteosclerotic myeloma.

  2013cited by this paper
• Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia.

  2013cited by this paper
• Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

  2012cited by this paper
• The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

  2012cited by this paper
• Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution.

  2011cited by this paper
• Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia

  2011cited by this paper
• Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia.

  2011cited by this paper
• A proportional hazards regression model for the subdistribution with right‐censored and left‐truncated competing risks data

  2011cited by this paper
• No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission.

  2011cited by this paper
• Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

  2011cited by this paper
• Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

  2010cited by this paper
• Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

  2010cited by this paper
• A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia.

  2010cited by this paper
• Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.

  2008cited by this paper
• Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

  2007cited by this paper
• Pediatric acute myeloid leukemia: towards high-quality cure of all patients

  2007cited by this paper
• Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.

  2006cited by this paper
• Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML.

  2006cited by this paper
• Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

  2005cited by this paper
• FLT3: ITDoes matter in leukemia

  2003cited by this paper
• Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.

  2003cited by this paper
• Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors

  2002cited by this paper
• A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.

  2001cited by this paper
• Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.

  1999cited by this paper
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999cited by this paper
• Some aspects of measurement error in explanatory variables for continuous and binary regression models.

  1998cited by this paper
• Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.

  1996cited by this paper
• Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood

  1996cited by this paper
• Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

  1995cited by this paper
• Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.

  1995cited by this paper
• Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes.

  1994cited by this paper
• Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.

  1994cited by this paper
• Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.

  1993cited by this paper
• Motor and Cognitive Testing of Bone Marrow Transplant Patients after Chemoradiotherapy

  1989cited by this paper
• Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

  1983cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper

• Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation: study rational and design

  2025cites this paper
• Excellent Outcomes of Hematopoietic Stem Cell Transplant for Pediatric High Risk and Relapsed Acute Myeloid Leukemia-A Decade Long Experience From Developing Nation.

  2025cites this paper
• Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP

  2025cites this paper
• Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCRαβ/CD19 depletion or post‐transplant cyclophosphamide

  2025cites this paper
• The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia

  2025cites this paper
• Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data

  2023cites this paper
• Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant

  2023cites this paper
• Pediatric chronic graft-versus-host disease-related dry eye disease and the diagnostic association of potential clinical findings

  2023cites this paper
• Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group

  2022cites this paper
• Survival of patients with acute leukemia after hematopoietic cell transplantation: A 8-years single-center study in Mexico

  2022cites this paper
• Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis

  2022cites this paper
• Pediatric Acute Myeloid Leukemia—Past, Present, and Future

  2022cites this paper
• Acute Leukemia in Infants

  2021cites this paper
• Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen

  2021cites this paper
• Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019

  2021cites this paper
• The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia

  2021influential citation
• Exploiting Clonal Evolution to Improve the Diagnosis and Treatment Efficacy Prediction in Pediatric AML

  2021cites this paper
• Impact of a Bayesian Individualization of Cyclosporine Dosage Regimen for Children Undergoing Allogeneic Hematopoietic Cell Transplantation: A Cost-Effectiveness Analysis

  2021cites this paper
• Risk factors and prognostic analysis of acute myeloid leukemia in children

  2021cites this paper
• Treatment Outcomes of Pediatric Acute Myeloid Leukemia in the Yeungnam Region: A Multicenter Retrospective Study of the Study Alliance of Yeungnam Pediatric Hematology–Oncology (SAYPH)

  2021cites this paper
• Targeted drugs in the treatment of acute myeloid leukemia in children

  2020cites this paper
• Haploidentical‐ versus identical‐sibling transplant for high‐risk pediatric AML: A multi‐center study

  2020cites this paper
• Minor Histocompatibility Antigen-Specific T Cells

  2020cites this paper
• Childhood Therapy-Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall.

  2020cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia in Brazil: A Multicentric Retrospective Study

  2020cites this paper
• Clinical Grade Production of Wilms’ Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation

  2020cites this paper
• Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation Compared With Chemotherapy as Postremission Treatment of Children With Intermediate-risk Acute Myeloid Leukemia in First Complete Remission.

  2020cites this paper
• Таргетные препараты в лечении острых миелоидных лейкозов у детей

  2020cites this paper
• Targeted Therapies for Pediatric AML: Gaps and Perspective

  2019cites this paper
• Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study

  2019cites this paper
• Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases

  2019cites this paper
• Retrospective analysis of children with high‐risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML‐05 clinical trial

  2019cites this paper
• Current status of umbilical cord blood transplantation in children

  2019cites this paper
• Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial

  2019cites this paper
• Acute Myeloid Leukemia in Children

  2018cites this paper
• Acute Myeloid Leukemia in Pediatric Patients: A Review About Current Diagnostic and Treatment Approaches

  2018cites this paper
• Preparing the Patient for HSCT: Conditioning Regimens and Their Scientific Rationale

  2018cites this paper
• Investigation of cytogenetic markers in neonatal blood spots and of aberrant protein expression in bone marrow from children with leukemia

  2018cites this paper
• Indications for Hematopoietic Stem Cell Transplantation in Children

  2018cites this paper
• Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience

  2017cites this paper
• Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.

  2017cites this paper
• Visual evoked potentials after hematopoietic allogeneic stem cell transplantation in childhood

  2017cites this paper
• Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group

  2017cites this paper
• Cord Blood Transplants for Myeloid Malignancies in Children

  2017cites this paper
• Factors Influencing the Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia: Single Institution Results from Saudi Arabia

  2017influential citation
• Single-centre experience of allogeneic haemopoietic stem cell transplant in paediatric patients in Cape Town, South Africa.

  2017cites this paper
• Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.

  2017cites this paper
• TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia

  2016cites this paper
• Haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience

  2016cites this paper
• haploidentical hematopoietic stem cell transplantation without total body irradiation for pediatric acute leukemia: a single-center experience

  2016cites this paper
• Cognate HLA absence in trans diminishes human NK cell education.

  2016cites this paper
• Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations

  2016cites this paper
• Autologous Cord Blood Cells Infusion as Salvage Therapy for Engraftment Failure After Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

  2016cites this paper
• Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis

  2016cites this paper
• Different aspects of stem cell procedures in children with poor responding AML: when is HSCT the best answer?

  2015cites this paper
• Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial

  2015cites this paper
• FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

  2015influential citation
• MicroRNA-519 enhances HL60 human acute myeloid leukemia cell line proliferation by reducing the expression level of RNA-binding protein human antigen R

  2015cites this paper
• Acute Myeloid Leukemia in Infants: Biology and Treatment

  2015cites this paper
• АЛЛОГЕННАЯ ТРАНСПЛАНТАЦИЯ ГЕМОПОЭТИЧЕСКИХ СТВОЛОВЫХ КЛЕТОК У ДЕТЕЙ: НАСТОЯЩЕЕ, ПРОБЛЕМЫ, ПЕРСПЕКТИВЫ

  2015cites this paper